RNAPub Date : 2025-02-28DOI: 10.1261/rna.080274.124
Susmit Narayan Chaudhury, Erdong Ding, Nathan Edward Jespersen, Jose N Onuchic, Karissa Y Sanbonmatsu
{"title":"Conformational heterogeneity in the dGsw purine riboswitch: role of Mg²⁺ and 2'-dG in aptamer folding.","authors":"Susmit Narayan Chaudhury, Erdong Ding, Nathan Edward Jespersen, Jose N Onuchic, Karissa Y Sanbonmatsu","doi":"10.1261/rna.080274.124","DOIUrl":"https://doi.org/10.1261/rna.080274.124","url":null,"abstract":"<p><p>Recent advancements in RNA structural biology have focused on unraveling the complexities of non-coding mRNA elements like riboswitches. These cis-acting regulatory regions undergo structural changes in response to specific cellular metabolites, leading to up or downregulation of downstream genes. The purine riboswitch family regulates many prokaryotic genes involved in purine degradation and biosynthesis. They feature an aptamer domain organized around a 3-way helical junction, where ligand encapsulation occurs at the junctional core. In our study, we chemically probed the aptamer domain of the 2'-dG-sensing purine riboswitch from Mesoplasma florum (dGsw) under various solution conditions to understand how Mg²⁺ and 2'-dG influence riboswitch folding. Here, we find that efficient 2'-dG binding strongly depends on Mg²⁺, indicating that Mg²⁺ is essential for priming dGsw for ligand interactions. We identified a previously undescribed sequence in the 5' tail of dGsw that is complementary to a conserved helix. The inclusion of this region in a construct led to intramolecular competition between the alternate helix, Palt, and P1. Mutational analysis confirmed that 5' flanking end of the aptamer domain forms an alternate helix in the absence of ligand. Molecular dynamics simulations revealed that this alternative conformation is stable. This helix may, therefore, facilitate the formation of an anti-terminator helix by opening the 3-way junction surrounding the 2'-dG binding site. Our study further establishes the importance of a closed terminal P1 helix conformation for metabolite binding and suggests that the delicate interplay between P1 and Palt may fine-tune downstream gene regulation. These insights offer a new perspective on riboswitch structure and enhance our understanding of the role that a conformational ensemble plays in riboswitch activity and regulation.</p>","PeriodicalId":21401,"journal":{"name":"RNA","volume":" ","pages":""},"PeriodicalIF":4.2,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143531459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RNAPub Date : 2025-02-21DOI: 10.1261/rna.080307.124
Brian H Carrick, Sarah L Crittenden, MaryGrace Linsley, Stephany J Costa Dos Santos, Marvin Wickens, Judith Kimble
{"title":"The PUF RNA-binding protein, FBF-2, maintains stem cells without binding to RNA.","authors":"Brian H Carrick, Sarah L Crittenden, MaryGrace Linsley, Stephany J Costa Dos Santos, Marvin Wickens, Judith Kimble","doi":"10.1261/rna.080307.124","DOIUrl":"10.1261/rna.080307.124","url":null,"abstract":"<p><p>Like all canonical PUF proteins, <i>C. elegans</i> FBF-2 binds to specific RNAs via tripartite recognition motifs (TRMs). Here we report that an FBF-2 mutant protein that cannot bind to RNA, is nonetheless biologically active and maintains stem cells. This unexpected result challenges the conventional wisdom that RBPs must bind to RNAs to achieve biological activity. Also unexpectedly, FBF-2 interactions with partner proteins can compensate for loss of RNA-binding. FBF-2 only loses biological activity when its RNA-binding and partner interactions are both defective. These findings highlight the complementary contributions of RNA-binding and protein partner interactions to activity of an RNA-binding protein.</p>","PeriodicalId":21401,"journal":{"name":"RNA","volume":" ","pages":""},"PeriodicalIF":4.2,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143472901","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RNAPub Date : 2025-02-19DOI: 10.1261/rna.080332.124
Zachery R Gregorich, Wei Guo
{"title":"Alternative splicing factors and cardiac disease: more than just missplicing?","authors":"Zachery R Gregorich, Wei Guo","doi":"10.1261/rna.080332.124","DOIUrl":"10.1261/rna.080332.124","url":null,"abstract":"<p><p>Alternative splicing (AS) is the process wherein the exons from a single gene are joined in different combinations to produce nonidentical, albeit related, RNA transcripts. This process is important for the development and physiological function of many organs and is particularly important in the heart. Notably, AS has been implicated in cardiac disease and failure, and a growing number of genetic variants in AS factors have been identified in association with cardiac malformation and/or disease. With the field poised to interrogate how these variants affect cardiac development and disease, an understandable point of emphasis will undoubtedly be on downstream target gene missplicing. In this Perspective article, we would like to encourage consideration not only of the potential for novel disease mechanisms, but also for contributions from disruption of the ever-expanding list of nonsplicing functions ascribed to many AS factors. We discuss the emergence of a novel cardiac disease mechanism based on pathogenic RNA granules and speculate on the generality of such a mechanism among localization-disrupting AS factor genetic variants. We also highlight emerging nonsplicing functions attributed to several AS factors with cardiac disease-associated genetic variants in the hopes of pointing to avenues for exploration of mechanisms that may contribute to disease alongside target gene missplicing.</p>","PeriodicalId":21401,"journal":{"name":"RNA","volume":" ","pages":"300-306"},"PeriodicalIF":4.2,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11874993/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142954234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RNAPub Date : 2025-02-19DOI: 10.1261/rna.080368.124
Pedro Bak-Gordon, James L Manley
{"title":"SF3B1: from core splicing factor to oncogenic driver.","authors":"Pedro Bak-Gordon, James L Manley","doi":"10.1261/rna.080368.124","DOIUrl":"10.1261/rna.080368.124","url":null,"abstract":"<p><p>Highly recurrent somatic mutations in the gene encoding the core splicing factor SF3B1 are drivers of multiple cancer types. SF3B1 is a scaffold protein that orchestrates multivalent protein-protein interactions within the spliceosome that are essential for recognizing the branchsite (BS) and selecting the 3' splice site during the earliest stage of pre-mRNA splicing. In this review, we first describe the molecular mechanism by which multiple oncogenic <i>SF3B1</i> mutations disrupt splicing. This involves perturbation of an early spliceosomal trimeric protein complex necessary for accurate BS recognition in a subset of introns, which leads to activation of upstream branchpoints and selection of cryptic 3' splice sites. We next discuss how specific transcripts affected by aberrant splicing in <i>SF3B1</i>-mutant cells contribute to the initiation and progression of cancer. Finally, we highlight the prognostic value and disease phenotypes of different cancer-associated <i>SF3B1</i> mutations, which is critical for developing new targeted therapeutics against <i>SF3B1</i>-mutant cancers still lacking in the clinic.</p>","PeriodicalId":21401,"journal":{"name":"RNA","volume":" ","pages":"314-332"},"PeriodicalIF":4.2,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11874996/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142954242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RNAPub Date : 2025-02-19DOI: 10.1261/rna.080277.124
Mackenzie L Davenport, Maurice S Swanson
{"title":"RNA gain-of-function mechanisms in short tandem repeat diseases.","authors":"Mackenzie L Davenport, Maurice S Swanson","doi":"10.1261/rna.080277.124","DOIUrl":"10.1261/rna.080277.124","url":null,"abstract":"<p><p>As adaptors, catalysts, guides, messengers, scaffolds, and structural components, RNAs perform an impressive array of cellular regulatory functions often by recruiting RNA-binding proteins (RBPs) to form ribonucleoprotein complexes (RNPs). While this RNA-RBP interaction network allows precise RNP assembly and the subsequent structural dynamics required for normal functions, RNA motif mutations may trigger the formation of aberrant RNP structures that lead to cell dysfunction and disease. Here, we provide our perspective on one type of RNA motif mutation, RNA gain-of-function mutations associated with the abnormal expansion of short tandem repeats (STRs) that underlie multiple developmental and degenerative diseases. We first discuss our current understanding of normal polymorphic STR functions in RNA processing and localization followed by an assessment of the pathogenic roles of STR expansions in the neuromuscular disease myotonic dystrophy. We also highlight ongoing questions and controversies focused on STR-based insights into the regulation of nuclear RNA processing and export as well as the relevance of the RNA gain-of-function pathomechanism for other STR expansion disorders in both coding and noncoding genes.</p>","PeriodicalId":21401,"journal":{"name":"RNA","volume":" ","pages":"349-358"},"PeriodicalIF":4.2,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11874975/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142897132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RNAPub Date : 2025-02-19DOI: 10.1261/rna.080382.125
Maria Carmo-Fonseca, Juan Valcárcel
{"title":"The unfolding landscape of RNA and disease.","authors":"Maria Carmo-Fonseca, Juan Valcárcel","doi":"10.1261/rna.080382.125","DOIUrl":"10.1261/rna.080382.125","url":null,"abstract":"","PeriodicalId":21401,"journal":{"name":"RNA","volume":"31 3","pages":"273-276"},"PeriodicalIF":4.2,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11874959/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143459385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RNAPub Date : 2025-02-19DOI: 10.1261/rna.080257.124
Takeshi Chujo, Kazuhito Tomizawa
{"title":"Mitochondrial tRNA modifications: functions, diseases caused by their loss, and treatment strategies.","authors":"Takeshi Chujo, Kazuhito Tomizawa","doi":"10.1261/rna.080257.124","DOIUrl":"10.1261/rna.080257.124","url":null,"abstract":"<p><p>Mitochondrial tRNA (mt-tRNA) modifications play pivotal roles in decoding and sustaining tRNA stability, thereby enabling the synthesis of essential respiratory complex proteins in mitochondria. Consequently, loss of human mt-tRNA modifications caused by mutations in the mitochondrial or nuclear genome can cause life-threatening mitochondrial diseases such as encephalopathy and cardiomyopathy. In this article, we first provide a comprehensive overview of the functions of mt-tRNA modifications, the responsible modification enzymes, and the diseases caused by the loss of mt-tRNA modifications. We then discuss progress and potential strategies to treat these diseases, including taurine supplementation for MELAS patients, targeted deletion of mtDNA variants, and overexpression of modification-related proteins. Finally, we discuss factors that need to be overcome to cure \"mitochondrial tRNA modopathies.\"</p>","PeriodicalId":21401,"journal":{"name":"RNA","volume":" ","pages":"382-394"},"PeriodicalIF":4.2,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11874988/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142885641","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RNAPub Date : 2025-02-19DOI: 10.1261/rna.080353.124
Gideon Dreyfuss
{"title":"RNA-binding proteins in disease etiology: fragile X syndrome and spinal muscular atrophy.","authors":"Gideon Dreyfuss","doi":"10.1261/rna.080353.124","DOIUrl":"10.1261/rna.080353.124","url":null,"abstract":"<p><p>All RNAs exist in complexes (RNPs) with RNA-binding proteins (RBPs). Studies in my lab since the 1980s have identified, sequenced and characterized the major pre-mRNA- and mRNA-RBPs (hnRNPs/mRNPs), revealing RNA-binding domains and common features of numerous RBPs and their central roles in posttranscriptional gene regulation. The first links between RBPs and RNPs to diseases emerged serendipitously for fragile X syndrome, as its gene (<i>FMR1</i>) encoded RBP (FMRP), and spinal muscular atrophy (SMA), caused by deficits in survival motor neurons (SMN). Discoveries of the SMN complex and its unanticipated function in RNP assembly, essential for spliceosomal snRNP biogenesis, advanced understanding of RNA biology and pathogenesis. I reflect on how these and other contributions (e.g., nucleocytoplasmic shuttling, telescripting) originated from curiosity-driven exploration and highly collaborative lab culture. The vast RNA and RBP assortments are beneficial, but increase complexity and chances of disorders, making the RNP sphere a rich source for future discoveries.</p>","PeriodicalId":21401,"journal":{"name":"RNA","volume":" ","pages":"277-283"},"PeriodicalIF":4.2,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11874976/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142855159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RNAPub Date : 2025-02-19DOI: 10.1261/rna.080280.124
Esteban Domingo, Brenda Martínez-González, Pilar Somovilla, Carlos García-Crespo, María Eugenia Soria, Ana Isabel de Ávila, Ignacio Gadea, Celia Perales
{"title":"A general and biomedical perspective of viral quasispecies.","authors":"Esteban Domingo, Brenda Martínez-González, Pilar Somovilla, Carlos García-Crespo, María Eugenia Soria, Ana Isabel de Ávila, Ignacio Gadea, Celia Perales","doi":"10.1261/rna.080280.124","DOIUrl":"10.1261/rna.080280.124","url":null,"abstract":"<p><p>Viral quasispecies refers to the complex and dynamic mutant distributions (also termed mutant spectra, clouds, or swarms) that arise as a result of high error rates during RNA genome replication. The mutant spectrum of individual RNA virus populations is modified by continuous generation of variant genomes, competition and interactions among them, environmental influences, bottleneck events, and bloc transmission of viral particles. Quasispecies dynamics provides a new perspective on how viruses adapt, evolve, and cause disease, and sheds light on strategies to combat them. Molecular flexibility, together with ample opportunity of mutant cloud traffic in our global world, are key ingredients of viral disease emergences, as exemplified by the recent COVID-19 pandemic. In the present article, we present a brief overview of the molecular basis of mutant swarm formation and dynamics, and how the latter relates to viral disease and epidemic spread. We outline future challenges derived of the highly diverse cellular world in which viruses are necessarily installed.</p>","PeriodicalId":21401,"journal":{"name":"RNA","volume":" ","pages":"429-443"},"PeriodicalIF":4.2,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11874995/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142847585","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
RNAPub Date : 2025-02-19DOI: 10.1261/rna.080334.124
Mary McMahon, Lynne E Maquat
{"title":"Exploring the therapeutic potential of modulating nonsense-mediated mRNA decay.","authors":"Mary McMahon, Lynne E Maquat","doi":"10.1261/rna.080334.124","DOIUrl":"10.1261/rna.080334.124","url":null,"abstract":"<p><p>Discovered more than four decades ago, nonsense-mediated mRNA decay (NMD) plays a fundamental role in the regulation of gene expression and is a major contributor to numerous diseases. With advanced technologies, several novel approaches aim to directly circumvent the effects of disease-causing frameshift and nonsense mutations. Additional therapeutics aim to globally dampen the NMD pathway in diseases associated with pathway hyperactivation, one example being Fragile X syndrome. In other cases, therapeutics have been designed to hijack or inhibit the cellular NMD machinery to either activate or obviate transcript-specific NMD by modulating pre-mRNA splicing. Here, we discuss promising approaches employed to regulate NMD for therapeutic purposes and highlight potential challenges in future clinical development. We are optimistic that the future of developing target-specific and global modulators of NMD (inhibitors as well as activators) is bright and will revolutionize the treatment of many genetic disorders, especially those with high unmet medical need.</p>","PeriodicalId":21401,"journal":{"name":"RNA","volume":" ","pages":"333-348"},"PeriodicalIF":4.2,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11874985/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142819036","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}